The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors

Kwai-Ming J. Cheung, Thomas P. Matthews, Karen Ball, Martin Rowlands, Kathy Boxall, Swee Sharp, Alison Maloney, S. Mark Roe, Chrisostomos Prodromou, Laurence Pearl, Wynne Aherne, Edward MacDonald, Paul Workman

Research output: Contribution to journalArticlepeer-review

Abstract

High-throughput screening identified the 3,4-diarylpyrazole CCT018159 as a novel and potent (7.1 μM) inhibitor of Hsp90 ATPase activity. Here, we describe the synthesis of CCT018159 and a number of close analogues together with data on their biochemical properties. Some initial structure–activity relationships are discussed, as well as the crystal structure of CCT018159 bound to Hsp90.
Original languageEnglish
Pages (from-to)3338-3343
JournalBioorganic & Medicinal Chemistry Letters
Volume15
Issue number14
DOIs
Publication statusPublished - 15 Jul 2005

Fingerprint

Dive into the research topics of 'The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors'. Together they form a unique fingerprint.

Cite this